Sanofi (SNY) Minority Interest (2009 - 2026)
Sanofi (SNY) posted Minority Interest of $418.5 million for Q2 2026, up 7.63% sequentially from $388.8 million in Q4 2025, and up 36.41% YoY from $306.8 million in Q2 2025.
Sanofi (SNY) Minority Interest (2009 - 2026) Analysis & Trends
Sanofi has reported Minority Interest for 18 years, with the latest figure at $418.5 million in Q2 2026.
- Quarterly Minority Interest rose 36.41% year-over-year to $418.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $418.5 million (up 36.41% YoY) and the FY2025 annual result came in at $388.8 million, up 3.95% from the prior year.
- Minority Interest advanced to $418.5 million in Q2 2026 per SNY's latest filing, from $388.8 million in the prior quarter.
- Over five years, Minority Interest peaked at $418.5 million in Q2 2026 and troughed at $306.8 million in Q2 2025.
- A 5-year average of $361.5 million and a median of $374.0 million in 2024 frame the typical range for Minority Interest.
- The sharpest annual moves came in 2022 and 2023: Minority Interest jumped 146.28% in 2022, then decreased 10.3% in 2023.
- Over 5 years, Minority Interest stood at $375.5 million in 2022, then fell by 10.3% to $336.8 million in 2023, then increased by 11.06% to $374.0 million in 2024, then increased by 3.95% to $388.8 million in 2025, then advanced by 7.63% to $418.5 million in 2026.
- According to Business Quant data, Minority Interest over the past three periods registered $418.5 million, $388.8 million, and $306.8 million for Q2 2026, Q4 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 418.45 Mn |
| Dec 31, 2025 | 388.79 Mn |
| Jun 30, 2025 | 306.76 Mn |
| Dec 31, 2024 | 374.01 Mn |
| Jun 30, 2024 | 330.60 Mn |
| Dec 31, 2023 | 336.77 Mn |
| Jun 30, 2023 | 346.28 Mn |
| Dec 31, 2022 | 375.45 Mn |
| Jun 30, 2022 | 376.67 Mn |
| Dec 31, 2021 | 400.39 Mn |
| Jun 30, 2021 | 152.94 Mn |
| Dec 31, 2020 | 174.07 Mn |
| Jun 30, 2020 | 200.47 Mn |
| Dec 31, 2019 | 192.60 Mn |
| Jun 30, 2019 | 185.40 Mn |
| Dec 31, 2018 | 181.48 Mn |
| Mar 31, 2018 | 202.71 Mn |
| Dec 31, 2017 | 198.99 Mn |
| Jun 30, 2017 | 177.03 Mn |
| Dec 31, 2016 | 183.55 Mn |